Artículos por temáticas

Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: A meta-analysis.

Zhang Y, Chen J, Xu C, Feng J, Li J.

Neurosci Lett. 2020 Jan 1;714:134544. doi: 10.1016/j.neulet.2019.134544. Epub 2019 Oct 28.

Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.

Li Y, Chen N, Wu C, Lu Y, Gao G, Duan C, Yang H, Lu L.

Brain Behav Immun. 2020 Jan;83:214-225. doi: 10.1016/j.bbi.2019.10.015. Epub 2019 Oct 25.

Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.

Mantas I, Yang Y, Mannoury-la-Cour C, Millan MJ, Zhang X, Svenningsson P.

Neuropharmacology. 2020 Jan 1;162:107829. doi: 10.1016/j.neuropharm.2019.107829. Epub 2019 Oct 24.

Validation of an Online Screener, the Mediterranean Eating Pattern for Americans-III in Older Patients with Parkinson's Disease.

Weaver KE, Goldman JG, Ribbens N, Rasmussen HE, Gustashaw KAR, Tangney CC.

J Nutr Gerontol Geriatr. 2020 Jan-Mar;39(1):30-43. doi: 10.1080/21551197.2019.1683116. Epub 2019 Oct 26.

Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications.

Rani L, Mondal AC.

Mitochondrion. 2020 Jan;50:25-34. doi: 10.1016/j.mito.2019.09.010. Epub 2019 Oct 22. Review.

Impaired metabolism of kynurenine and its metabolites in CSF of parkinson's disease.

Iwaoka K, Otsuka C, Maeda T, Yamahara K, Kato K, Takahashi K, Takahashi K, Terayama Y.

Neurosci Lett. 2020 Jan 1;714:134576. doi: 10.1016/j.neulet.2019.134576. Epub 2019 Oct 22.

Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats.

Sharma S, Raj K, Singh S.

Neurotox Res. 2020 Jan;37(1):198-209. doi: 10.1007/s12640-019-00120-z. Epub 2019 Oct 25.

Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model.

Xue B, Xiao W, Tian H.

Biochem Biophys Res Commun. 2020 Jan 1;521(1):245-251. doi: 10.1016/j.bbrc.2019.10.118. Epub 2019 Oct 22.

Initiation of Parkinson's disease from gut to brain by δ-secretase.

Ahn EH, Kang SS, Liu X, Chen G, Zhang Z, Chandrasekharan B, Alam AM, Neish AS, Cao X, Ye K.

Cell Res. 2020 Jan;30(1):70-87. doi: 10.1038/s41422-019-0241-9. Epub 2019 Oct 24.

Managing Parkinson's disease: moving ON with NOP.

Mercatelli D, Bezard E, Eleopra R, Zaveri NT, Morari M.

Br J Pharmacol. 2020 Jan;177(1):28-47. doi: 10.1111/bph.14893. Epub 2020 Jan 3. Review.

A phase 2, open-label, multi-center study to evaluate the efficacy and safety of (99m)Tc-TRODAT-1 SPECT to detect Parkinson's disease.

Sun Y, Liu C, Chen Z, Li B, Lv Z, Lou J, Tang J, Wang Y, Zhang G, Liu X.

Ann Nucl Med. 2020 Jan;34(1):31-37. doi: 10.1007/s12149-019-01412-2. Epub 2019 Oct 23. Erratum in: Ann Nucl Med. 2020 Jan 10;:.

Visual search and target detection during simulated driving in Parkinson's disease.

Ranchet M, Morgan JC, Akinwuntan AE, Devos H.

Accid Anal Prev. 2020 Jan;134:105328. doi: 10.1016/j.aap.2019.105328. Epub 2019 Oct 19.

Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

Junior NCF, Dos-Santos-Pereira M, Guimarães FS, Del Bel E.

Neurotox Res. 2020 Jan;37(1):12-29. doi: 10.1007/s12640-019-00109-8. Epub 2019 Oct 22. Review.

Impact of prefrontal intermittent theta-burst stimulation on working memory and executive function in Parkinson's disease: A double-blind sham-controlled pilot study.

Hill AT, McModie S, Fung W, Hoy KE, Chung SW, Bertram KL.

Brain Res. 2020 Jan 1;1726:146506. doi: 10.1016/j.brainres.2019.146506. Epub 2019 Oct 18.

Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study.

Pacheco-Paez T, Montastruc F, Rousseau V, Chebane L, Lapeyre-Mestre M, Renoux C, Montastruc JL.

Mov Disord. 2020 Jan;35(1):176-180. doi: 10.1002/mds.27876. Epub 2019 Oct 21.